| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4005331 | American Journal of Ophthalmology | 2008 | 10 Pages |
Abstract
Eyes with neovascular AMD treated with intravitreal bevacizumab over 12 months had significant anatomical and functional improvement. Further studies need to confirm the long-term efficacy of this treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Ziad F. Bashshur, Zeina A. Haddad, Alexandre Schakal, Rola F. Jaafar, Marc Saab, Baha' N. Noureddin,